Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CES 2023: Abbott, Seth Rogen, An Avatar For Old Folks, And A Smart Toilet For The Heartbroken

Executive Summary

In this first roundup of innovative digital health solutions showcased at CES 2023, Medtech Insight highlights Abbott’s award-winning tech, an AARP-sponsored panel discussion on Alzheimer’s with Seth and Lauren Miller Rogen, Care.coach, and Casana, a smart toilet for monitoring patients with heart disease.

You may also be interested in...



Freshest In Agetech Headed For CES 2024: Meet Your Life-Size Hologram, Experience Being 80, Visit A (Really) Smart Home

AARP is putting AgeTech squarely on the map at CES 2024 with the largest booth at Sands Expo Convention Center, featuring 21 start-ups, 26 sessions, live improv, and demos. 

Abbott Gains FDA Clearance For Lab-Based Concussion Test

Abbott said it received the US FDA nod to run its blood-based test to assess patients for concussions on its Alinity i laboratory instrument. This will make the test more widely available in hospitals and laboratories in the US.

Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent CES 2023 conference in Las Vegas. Reed Miller discusses Abbott’s VR partnership with the Blood Centers for America and Barnaby Pickering highlights Bayer’s jump into medtech with its buyout of Blackford Analysis.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel